SNDL completes EU-GMP audit at New Brunswick cannabis facility

Go back to SNDL completes EU-GMP audit at New Brunswick cannabis facility

SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility

August 4, 2026 4:30 PM EDT

EDMONTON, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (SNDL or the Company) today announced the successful completion of a European Union Good Manufacturing Practice ("EU-GMP") audit at its Atholville, New Brunswick cultivation facility.

The successful audit reinforces SNDLs ability to participate in regulated international medical cannabis markets and reflects the Companys continued focus on quality, operational excellence, and regulatory compliance. EU-GMP compliance is an important standard for supplying medical cannabis products into many international jurisdictions. The Company anticipates... More